Clinical trial
Buprenorphine and Naloxone Combination Study - 10
NCT00015288 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00015288 |
|---|---|
| Title | Buprenorphine and Naloxone Combination Study - 10 |
| Official title | PK0496 Pharmacokinetics of Buprenorphine |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | New York MDRU |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Heroin Dependence, Opioid-Related Disorders |
| Intervention type | Drug |
| Interventions | Buprenorphine/naloxone |
| Enrollment | 0 |
| Start date | Nov 1, 1996 |
| First posted | Apr 18, 2001 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: